| 11/19/2024 | BKEMHY | S&P raises Teva
|
| 10/10/2024 | BKEMHY | Moody’s raises Teva view to positive
|
| 9/18/2024 | BKEMHY | Fitch raises Teva
|
| 6/24/2024 | BKCVEMHY | S&P turns Teva outlook to positive
|
| 3/7/2024 | BKEMHY | Fitch revises Teva outlook to positive
|
| 5/31/2023 | BKCVEMHY | S&P turns Teva outlook to stable
|
| 3/13/2023 | EMHYLM | Teva gives results, ups caps in offer for $2.5 billion of notes
|
| 3/6/2023 | BKCVEMHY | S&P assigns BB- to Teva notes
|
| 3/1/2023 | HY | Market Commentary: Junk primary prices $3.65 billion; Triumph flat in secondary; Adient stumbles, recovers
|
| 3/1/2023 | EMGNHY | New Issue: Teva prices upsized $2.49 billion equivalent sustainability notes in four tranches
|
| 3/1/2023 | BKCVEMGNHY | Fitch assigns BB- to Teva notes
|
| 3/1/2023 | EMGNHY | Teva upsizes to $2.49 billion, hones talk on four-part notes offering; pricing Wednesday
|
| 2/28/2023 | HY | Market Commentary: Junk: $2.2 billion of new paper; Consolidated Communications falls; Ranger Oil spikes
|
| 2/28/2023 | EMGNHY | Moody's assigns Ba2 to Teva notes
|
| 2/28/2023 | EMGNHY | Teva sets talk in $2.06 billion four-part sustainability-linked notes offering; pricing Wednesday
|
| 2/27/2023 | HY | Market Commentary: Triumph, Teva on deck; Tegna tanks on FCC acquisition opposition; TransDigm, Uniti improve
|
| 2/27/2023 | EMHYLM | Teva starts tender offer for $2.25 billion of notes due 2023 to 2026
|
| 2/27/2023 | EMGNHY | Teva starts roadshow for $2.06 billion four-part offering of sustainability-linked notes
|
| 2/24/2023 | HY | Market Commentary: Junk moves lower on inflation data; TransDigm lower; Medical Properties pressured
|
| 2/24/2023 | EMHY | Israel’s Teva sets non-deal roadshow via Citigroup and Goldman Sachs in week ahead
|
| 7/29/2022 | BKCVEMGNHY | S&P lifts Teva outlook to positive
|
| 7/27/2022 | HY | Market Commentary: Pharma bonds mixed following Teva opioid settlement; Endo mostly lower; Bausch improves
|
| 7/27/2022 | HY | Market Commentary: Avient prices; secondary surges post-Fed; cross-over credits in demand; Teva gains on settlement
|
| 12/15/2021 | BKCVEMGNHY | Moody's turns Teva outlook to stable
|
| 12/6/2021 | BKCVEMGNHY | Fitch revises Teva view to stable
|
| 11/10/2021 | EMHYLM | Teva gives early tender results for six series, lifts cap to $4 billion
|
| 11/5/2021 | HY | Market Commentary: Morning Commentary: United Site 8% notes 103 bid; PIK toggle dividend deals return
|
| 11/4/2021 | HY | Market Commentary: DCP Midstream, Asbury Automotive price; Teva active; Continental gains; CommScope sinks
|
| 11/3/2021 | HY | Market Commentary: Junk secondary unmoved by Fed tapering statement; Teva flat; Jane Street on a 101-handle
|
| 11/2/2021 | HY | Market Commentary: Jane Street, Teva price HY bonds; Mr. Cooper improves; Navient flat; Molina struggles
|
| 11/2/2021 | EMGNHY | New Issue: Teva Pharmaceutical prices upsized $5 billion equivalent sustainability-linked notes
|
| 11/1/2021 | HY | Market Commentary: Mr. Cooper, Navient price; loanDepot gains on earnings beat; PG&E active
|
| 11/1/2021 | EMGNHY | Teva sets price talk in $4 billion equivalent four-part sustainability notes offer, pricing Tuesday
|
| 10/27/2021 | HY | Market Commentary: CA Magnum/Hexaware prices; Roblox struggles in junkland; Gray Television on a 101-handle
|
| 10/27/2021 | EMGNHY | Junk investors dig in on Teva’s $4 billion four-part offering of sustainability-linked notes
|
| 10/27/2021 | EMHYLM | Teva Pharmaceutical commences capped cash tender offer for six series of notes
|
| 10/27/2021 | EMHY | S&P assigns Teva notes BB-
|
| 10/27/2021 | EMHYLM | Teva Pharmaceutical begins cash tender offer for six series of notes
|
| 10/27/2021 | EMGNHY | Teva markets $4 billion equivalent dollar, euro sustainability notes; pricing expected Tuesday
|
| 10/27/2021 | EMGNHY | Teva markets $4 billion equivalent dollar, euro sustainability notes
|
| 10/27/2021 | EMHY | Moody's rates Teva notes Ba2
|
| 9/3/2020 | BKCVEMHY | S&P trims Teva
|
| 11/25/2019 | DDEMHYLM | Teva gives early results for tenders for 2.2%, 3.65% notes due 2021
|
| 11/21/2019 | EMHYLM | Teva Pharmaceutical to redeem €650 million of 3/8% notes
|
| 11/19/2019 | EMHY | New Issue: Teva Pharmaceutical prices $1 billion 7 1/8% notes and €1 billion 6% notes at par
|
| 11/19/2019 | EMHY | Teva Pharmaceutical upsizes bond tranches, tightens talk amid huge demand; pricing Tuesday
|
| 11/19/2019 | EMHY | Teva Pharmaceutical ups bond tranches to $1 billion and €1 billion, tightens talk; pricing Tuesday
|
| 11/18/2019 | HY | Market Commentary: iHeart, Boyd, Mattel, MSCI add-on price; Prestige Brands, Univar, Maxar trade up; Intelsat sinks
|
| 11/18/2019 | EMHY | Teva sets tranches, talk for upsized $2 billion equivalent long five-year dual-currency notes
|
| 11/15/2019 | HY | Market Commentary: Univar, Maxar, Prestige price; Centene plans $7 billion; Hertz, Restaurant Brands up
|
| 11/13/2019 | HY | Market Commentary: Wesco clears the market; Targa prices; Sealed Air, goeasy lag; Outfront, Scientific Games trade up
|
| 11/13/2019 | EMHY | Teva Pharmaceutical sets initial price talk in $1.5 billion dollar, euro notes offering
|
| 11/8/2019 | HY | Market Commentary: Teva rises after starting tender offers; Revlon notes head lower following earnings
|
| 11/8/2019 | HY | Market Commentary: Wesco PattonAir downsizes; Albertsons improves; LPL up; Teva active; Wildhorse rebounds
|
| 11/8/2019 | HY | Market Commentary: Wesco PattonAir downsizes; Albertsons improves; LPL up; Teva active; Wildhorse rebounds
|
| 11/8/2019 | DDEMHYLM | Teva tenders for 2.2%, 3.65% notes, will spend up to $1.5 billion
|
| 11/8/2019 | EMHY | Teva Pharmaceutical sets roadshow for $1.5 billion two-part bullet deal in dollars and euros
|
| 11/7/2019 | HY | Market Commentary: Party City dives after earnings miss; Teva trades mixed on guidance, CFO appointment
|
| 10/24/2019 | HY | Market Commentary: PG&E notes trade lower amid more power blackouts; Teva paper declines in pharma space
|
| 10/22/2019 | HY | Market Commentary: Netflix, Liberty Cablevision price; euro junk market sees tightest print ever; newer notes rise
|
| 10/21/2019 | HY | Market Commentary: United Rentals, KB Home price; newer notes trade; Teva lifted; Coty falls; WeWork higher
|
| 10/21/2019 | HY | Market Commentary: McDermott notes drop on rescue financing; Teva lifted after opioid settlement news
|
| 10/18/2019 | HY | Market Commentary: Neptune Energy adds; Evoca prices; Thursday issuance higher; Teva up; WeWork better
|
| 10/18/2019 | HY | Market Commentary: L Brands bonds active after analyst comments; Teva Pharmaceutical notes edge higher
|
| 10/17/2019 | HY | Market Commentary: Europe primary active; Charter, Speedway, Merlin trading up; Netflix moves higher
|
| 10/17/2019 | HY | Market Commentary: Teva active as settlement reportedly nears; Gulfport Energy rises on production news
|
| 10/16/2019 | HY | Market Commentary: Merlin, Speedway price; new Charter notes rise; pharma names lifted; Sprint, T-Mobile higher
|
| 10/16/2019 | HY | Market Commentary: Pharma names improve on settlement news; Rite Aid declines after ratings downgrade
|
| 9/20/2019 | HY | Market Commentary: McDermott better on asset sale talk; PG&E paper rises amid dueling reorganization plans
|
| 9/19/2019 | HY | Market Commentary: Chesapeake Energy notes lower after senior note swap; Teva weakens in pharma space
|
| 8/28/2019 | HY | Market Commentary: Pharma space under pressure; Rackspace higher; Tallgrass negative; oil names rise
|
| 8/28/2019 | HY | Market Commentary: Pharma names lower on more settlement news; Rackspace improves after conference call
|
| 8/27/2019 | HY | Market Commentary: Pharma names see negativity; Range Resources varies; GTT declines
|
| 8/27/2019 | HY | Market Commentary: Endo, Teva drop post-settlement news; Range Resources active, flat after downgrade
|
| 8/22/2019 | HY | Market Commentary: L Brands bonds active, mixed after earnings report; CBL eyed after delisting notice
|
| 8/21/2019 | HY | Market Commentary: L Brands lower on earnings anticipation; Endo International notes continue to rise
|
| 8/20/2019 | HY | Market Commentary: PG&E continues to decline; Endo gains after settling suit; Tenet varies
|
| 8/20/2019 | HY | Market Commentary: Endo International gains after lawsuit settlement news; PG&E weakens in utilities space
|
| 8/15/2019 | HY | Market Commentary: J.C. Penney better after earnings report; PG&E drops on negative report
|
| 8/14/2019 | HY | Market Commentary: Teva drops on negative outlook, government pressure; Dean lower on agency downgrade
|
| 8/13/2019 | HY | Market Commentary: GTT better on ownership disclosure; Mattel gains on global trade news
|
| 8/13/2019 | HY | Market Commentary: Post Labor Day pipeline eyed; Tenet Healthcare bounces off lows; Teva drops; Goodyear Tire rises
|
| 8/9/2019 | HY | Market Commentary: Exela crashes on disappointing earnings; Mallinckrodt lower amid lawsuit news
|
| 8/8/2019 | HY | Market Commentary: GTT, Rayonier dive on quarterly misses; Teva rises in pharma space
|
| 8/7/2019 | HY | Market Commentary: Frontier, Teva down despite earnings beat; Denbury rises after quarterly numbers
|
| 8/6/2019 | HY | Market Commentary: Endo rises despite negative earnings, sector negativity; Adient gains on quarterly report
|
| 8/5/2019 | HY | Market Commentary: Diamond Offshore dives after earnings miss; Chemours down in chemicals space
|
| 8/2/2019 | HY | Market Commentary: California Resources, Valaris fall post-earnings; Chemours off in chemical space
|
| 7/31/2019 | HY | Market Commentary: Range Resources better post earnings; Frontier active, diverge in telecom space
|
| 7/30/2019 | HY | Market Commentary: McDermott slips after earnings, guidance; Intelsat better on mixed earnings
|
| 7/29/2019 | HY | Market Commentary: Teva higher as settlement reached; LSC Communications declines on downgrade
|
| 7/25/2019 | HY | Market Commentary: Diebold Nixdorf up after earnings, maturities news; PG&E lower as wildfire fund detailed
|
| 7/23/2019 | HY | Market Commentary: Bed Bath & Beyond mixed on layoff news; LSC notes tank after merger cancelled
|
| 7/23/2019 | HY | Market Commentary: JBS USA, Five Point add-on price; Teva in focus; LSC Communications craters; Realogy rebounds
|
| 7/22/2019 | HY | Market Commentary: Mallinckrodt dips on negative attention; Halcon Resources lower on restructuring chatter
|
| 7/19/2019 | HY | Market Commentary: Mallinckrodt’s woes continue; Teva drops; J.C. Penney explores options
|
| 7/15/2019 | HY | Market Commentary: Endo, Teva under pressure; Intelsat drops; Cincinnati Bell recoups losses
|
| 7/15/2019 | HY | Market Commentary: Trivium, Trident TPI on tap; E.W. Scripps, Masonite improve; Carrizo Oil & Gas up on buyout
|
| 7/11/2019 | HY | Market Commentary: Bed Bath & Beyond down after earnings; PG&E better on fund approval
|
| 7/5/2019 | HY | Market Commentary: Trading light; Altice USA backs off gains; Teva active but flat; funds add $800 million
|
| 7/5/2019 | HY | Market Commentary: Weatherford better as DIP financing approved; Teva down in pharma space
|
| 7/1/2019 | HY | Market Commentary: Weatherford drops on bankruptcy filing; Endo lower after ratings downgrade
|
| 6/28/2019 | HY | Market Commentary: Digicel drops after earnings miss; PetSmart better as debt upgraded; Rite Aid better
|
| 6/26/2019 | HY | Market Commentary: Ensco Rowan jumps; energy trends higher; Frontier mixed amid ratings downgrade
|
| 6/25/2019 | HY | Market Commentary: PG&E lower as creditors propose restructure plan; GTT slides on analyst downgrade
|
| 6/24/2019 | HY | Market Commentary: PG&E rises after restructure plan floated; Teva mixed as settlement approved
|
| 6/18/2019 | HY | Market Commentary: Windstream higher as Uniti lease in question; PetSmart declines in retail
|
| 6/17/2019 | HY | Market Commentary: Denbury mixed as early exchange results come in; Frontier lower in telecom space
|
| 6/14/2019 | HY | Market Commentary: PetSmart better on Chewy IPO; Frontier lower amid restructure talk
|
| 6/13/2019 | HY | Market Commentary: Hertz spikes on rights offering; Frontier mixed in telecom space
|
| 6/12/2019 | HY | Market Commentary: Frontier lower on analyst downgrade; Teva down on settlement news
|
| 6/11/2019 | HY | Market Commentary: Hexion mixed as term loan prepped; Legacy Reserves down on bankruptcy talk
|
| 6/7/2019 | HY | Market Commentary: Frontier lower on board appointments; Teva mixed as ratings downgraded
|
| 6/6/2019 | HY | Market Commentary: Intelsat rises as new issue prices; Mallinckrodt slumps in settlement reaction
|
| 6/5/2019 | HY | Market Commentary: Mallinckrodt better after settling suit; L Brands down as tender offer starts
|
| 6/4/2019 | HY | Market Commentary: PetSmart up as Chewy valuation increases; Teva rises in pharma space
|
| 6/3/2019 | HY | Market Commentary: Multi-Color, Grubhub on tap; Neiman Marcus, GCI price; Teva in focus, gains; Altice up
|
| 6/3/2019 | HY | Market Commentary: Teva better after analyst upgrade; Navios mixed on debt offering
|
| 5/31/2019 | HY | Market Commentary: U.S. Steel down on tariff news; Teva mixed after negative week
|
| 5/30/2019 | HY | Market Commentary: PetSmart improves on Chewy valuation; Teva loses on analyst scrutiny
|
| 5/29/2019 | HY | Market Commentary: CNO Financial prices; Frontier gains; Teva’s downward spiral continues; CRC drops
|
| 5/29/2019 | HY | Market Commentary: Frontier gains on asset sale news; Teva loses in settlement reaction
|
| 5/28/2019 | HY | Market Commentary: CNO Financial, GoDaddy on tap; Fiat up on merger; Teva drops post settlement
|
| 5/28/2019 | HY | Market Commentary: Teva lower as company settles suit; Navios mixed amid debt swap
|
| 5/24/2019 | HY | Market Commentary: Exela continues on downward track; Ensco Rowan sees upward push
|
| 5/23/2019 | HY | Market Commentary: Exela pushed into distressed territory; L Brands rises after earnings report
|
| 5/22/2019 | HY | Market Commentary: Mallinckrodt lower on ratings downgrade; DISH mixed after acquiring assets
|
| 5/21/2019 | HY | Market Commentary: Mallinckrodt dives after legal move; J.C. Penney down post-earnings
|
| 5/20/2019 | HY | Market Commentary: Alta Mesa lower on SEC investigation; U.S. Steel negative after trade news
|
| 5/17/2019 | HY | Market Commentary: Dean Foods down after ratings downgrade; U.S. Steel lower on trade news
|
| 5/16/2019 | HY | Market Commentary: U.S. Steel rises despite trade climate; Navios gains after asset manager buys stake
|
| 5/15/2019 | HY | Market Commentary: Transocean prices; Berry on tap; VistaJet active; Teva, Commscope under pressure; BWAY gains
|
| 5/15/2019 | HY | Market Commentary: Teva lower on continued scrutiny; Chaparral Energy drops after downgrade
|
| 5/14/2019 | HY | Market Commentary: Intelsat rises on 5G development; Halcon gains despite ratings downgrade
|
| 5/13/2019 | HY | Market Commentary: Teva loses as legal troubles mount; Weatherford drops as bankruptcy expected
|
| 5/13/2019 | HY | Market Commentary: Eldorado on tap; Bausch Health weakens; Charter below par; Weatherford, Teva down
|
| 5/7/2019 | HY | Market Commentary: Dean Foods better despite negative earnings; Mallinckrodt mixed on earnings beat
|
| 5/3/2019 | HY | Market Commentary: California Resources mixed post-earnings; PetSmart jumps as outlook changed
|
| 5/2/2019 | HY | Market Commentary: Ensco Rowan, PG&E slip post-earnings; Teva Pharmaceutical lower after mixed earnings results
|
| 4/25/2019 | HY | Market Commentary: California Resources dips; Adient rises as subsidiary prices new issue
|
| 4/23/2019 | HY | Market Commentary: Air Methods higher as earnings trickle out; PG&E higher as new director named
|
| 4/10/2019 | HY | Market Commentary: Rite Aid mixed as company decides on stock split; Intelsat lower on satellite problems
|
| 3/28/2019 | HY | Market Commentary: PG&E mixed as creditors propose bankruptcy exit plan; Endo off on early tender results
|
| 3/26/2019 | HY | Market Commentary: Endo up as sector peer settles lawsuit; Bed Bath & Beyond rises as investors push CEO exit
|
| 3/14/2019 | HY | Market Commentary: Endo notes positive as company begins debt refinancing; PHI issues down on maturity fears
|
| 2/26/2019 | HY | Market Commentary: Alta Mesa notes crash after financial reporting news; Windstream issues gain
|
| 2/22/2019 | HY | Market Commentary: Windstream drops on bankruptcy concerns; Halcon falls following CEO departure
|
| 2/20/2019 | HY | Market Commentary: Intelsat rises despite earnings miss; FirstEnergy gains as earnings beat estimates
|
| 2/19/2019 | HY | Market Commentary: Windstream notes crash after legal battle lost; PHI issues drop as pressure mounts
|
| 2/15/2019 | HY | Market Commentary: Ensco, Rowan notes gain as regulator approves merger; Univision issues recover
|
| 2/14/2019 | HY | Market Commentary: McDermott notes continue fall after cost overrun report; Univision issues leak
|
| 2/13/2019 | HY | Market Commentary: Teva notes drop after Q4 profit loss; Diebold issues surge after revenue tops expectations
|
| 1/14/2019 | HY | Market Commentary: PG&E crashes on bankruptcy news; Ensco mixed as company seeks to alter Rowan deal
|
| 1/4/2019 | HY | Market Commentary: Risk-on sentiment returns; CDX sees largest single-day gain in four years; energy outperforms
|
| 1/3/2019 | HY | Market Commentary: No new deals in sight; trading volume light; Western Digital active; Qorvo drops; Xerox, Teva gain
|
| 12/7/2018 | HY | Market Commentary: Mallinckrodt notes move lower as market reacts to spinoff news; Neiman Marcus down
|
| 11/1/2018 | BKBWCVEMHY | Israel’s Teva is using majority of cash flow to reduce leverage to 3x
|
| 10/11/2018 | HY | Market Commentary: Millicom prices; TransDigm rises on acquisition; energy mixed; Teva Pharaceutical improves
|
| 9/18/2018 | EMHYLM | Israel’s Teva to buy some 1.7%, 3/8% notes in oversubscribed tender
|
| 9/14/2018 | BWEMHY | Teva sees slump in profits, rise in debt due to Copaxone competition
|
| 9/4/2018 | EMHYLM | Israel’s Teva to pay up to $400 million in tenders for three issues
|
| 7/27/2018 | HY | Market Commentary: Hi-Crush prices, euro primary active; Party City’s new issue lower; Teva slides
|
| 7/26/2018 | HY | Market Commentary: Party City prices; Teva improves; Aleris acquired; SuperValu bought; funds off $548 million
|
| 7/20/2018 | HY | Market Commentary: Comstock prices; Bruin carried over; secondary trading light; IHS Markit eyed; Teva active
|
| 7/2/2018 | HY | Market Commentary: Primary, secondary quiet pre-holiday; recent deals unchanged; Teva, HCA active; ATD gains
|
| 3/16/2018 | HY | Market Commentary: Tullow, Husky lead busy primary; Mattel trades on Toys shutdown; Teva still trades under par
|
| 3/13/2018 | BWEMHY | Teva’s upsized bond sale goes ‘very well’; pricing on low end of talk
|
| 3/7/2018 | HY | Market Commentary: Upsized Teva megadeal prices; new Ball notes busiest; CIT trades up; Frontier mostly up ahead of deal
|
| 3/7/2018 | HY | Market Commentary: Upsized Teva megadeal prices; new Ball notes busiest; CIT trades up; Frontier mostly up ahead of deal
|
| 3/7/2018 | EMHY | New Issue: Teva Pharmaceutical sells upsized $4.5 billion equivalent notes in four tranches
|
| 3/7/2018 | HY | Market Commentary: Morning Commentary: CIT subordinated paper soars into secondary; Teva launches upsized $4.5 billion
|
| 3/7/2018 | EMHY | Israel’s Teva launches upsized $4.5 billion four-part bond deal; pricing expected Wednesday
|
| 3/6/2018 | HY | Market Commentary: Three-part CIT drive-by leads deal parade; Ball, William Lyons, Buena Vista also price; Teva on tap
|
| 3/6/2018 | EMHY | Teva Pharmaceutical sets price talk in $3.5 billion four-part deal; books close Wednesday
|
| 3/2/2018 | HY | Market Commentary: Smaller, restructured Meritage caps $3.49 billion primary week; New Enterprise notes busy
|
| 2/28/2018 | EMHY | Teva Pharmaceutical sets roadshow for $3.5 billion equivalent four-part bullet notes
|
| 2/1/2018 | HY | Market Commentary: Upsized JBS prices, also Indigo, Oceaneering; new Indigo firms; energy up as crude gains
|
| 1/17/2018 | HY | Market Commentary: Noble deal upsizes; RCN Grande, Itron add-on, split-rated Toll also price; Tuesday deals trade actively
|
| 12/14/2017 | BKBWCVHYIG | Teva to use all available cash flow to cut debt until end of 2020
|
| 7/20/2016 | EMHYMUPFPV | Market Commentary: Primary action thins; Citi subordinated notes mixed; Teva stronger; credit spreads firm
|
| 7/18/2016 | EMHYMUPFPV | Market Commentary: Teva prices $15 billion; Citi, Wells Fargo tap market; bonds mixed; credit spreads improve
|
| 7/13/2016 | EMHYMUPFPV | Market Commentary: Japan Bank, Bank of Montreal, International Finance in primary; Anheuser-Busch flat on day
|
| 3/24/2015 | HYIG | Market Commentary: New deal from Teva Pharmaceuticals; risk aversion grows; Asia mixed, Lat-Am weakens
|
| 5/3/2011 | BKCACVHY | Moody's confirms Valeant
|
| 11/15/2002 | HY | American Tower gains sharply on hopes of exchange offer; 3M, Teva continue northward
|
